Optimi Health Corp. (OPTH) Income Statement
OPTH FY2025 at a glance
Fiscal year ended September 30, 2025 · Canadian dollarsOPTH revenue and net income
Where OPTH's revenue goes
FY2025Each bar shows an amount and its share of revenue. OPTH kept −870.8% of revenue as net income.
OPTH profit margins
OPTH growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +9.5% | +74.2% | — | — |
| Gross profit | −866.5% | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OPTH income statement in Canadian dollars
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | C$426,904 | C$389,850 | C$181,087 | C$80,717 | C$0 | C$0 |
| Cost of revenue | C$2.5M | C$118,940 | C$338,124 | C$26,799 | C$47,120 | C$5,425 |
| Gross profit | −C$2.1M | C$270,910 | −C$157,037 | C$53,918 | −C$47,120 | −C$5,425 |
| Research & development | C$348,190 | C$144,473 | C$152,146 | C$133,235 | C$240,924 | — |
| Sales, general & admin | C$2.7M | C$4.0M | C$3.9M | C$6.1M | C$5.1M | C$483,423 |
| Total operating expenses | C$2.5M | C$5.9M | C$4.2M | C$7.4M | C$6.1M | C$483,423 |
| Operating income | −C$4.5M | −C$5.6M | −C$4.4M | −C$7.4M | −C$6.1M | −C$483,423 |
| Interest income | C$14,313 | C$2,665 | C$136,410 | C$66,943 | — | — |
| Interest expense | C$532,432 | C$429,339 | C$43,707 | C$27,993 | C$19,184 | C$7,908 |
| Income before taxes | −C$3.7M | −C$6.0M | −C$5.2M | −C$7.4M | −C$6.0M | −C$507,663 |
| Income taxes | — | — | — | — | — | C$5 |
| Net income | −C$3.7M | −C$6.0M | −C$5.2M | −C$7.4M | −C$6.0M | −C$507,663 |
| EBITDA | −C$2.2M | −C$4.7M | −C$4.4M | −C$7.0M | −C$6.0M | −C$499,695 |
| Gross margin | −486.4% | 69.5% | −86.7% | 66.8% | — | — |
| Operating margin | −1,062.3% | −1,438.8% | −2,419.1% | −9,155.2% | — | — |
| Net margin | −870.8% | −1,548.3% | −2,868.5% | −9,106.9% | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | C$98,700 | C$99,500 | C$0 | C$0 | C$196,389 | C$61,241 | C$232,700 | C$57,859 | C$124,027 | C$82,890 | C$105,074 | C$19,925 |
| Cost of revenue | C$397,404 | C$10,036 | C$264,532 | C$400,204 | C$14,456 | C$17,298 | C$62,473 | C$83,442 | C$62,106 | C$701,060 | −C$71,049 | −C$114,893 |
| Gross profit | −C$298,703 | C$89,464 | −C$264,532 | −C$464,233 | C$181,933 | C$43,943 | C$170,227 | −C$5,583 | C$61,921 | −C$618,170 | C$176,123 | C$134,818 |
| Research & development | C$82,724 | C$38,799 | C$48,455 | C$144,200 | C$1,500 | C$42,239 | C$201,998 | C$129,810 | C$176,587 | C$170,537 | C$8,613 | C$5,022 |
| Sales, general & admin | C$675,665 | C$778,000 | C$665,132 | C$792,471 | C$515,119 | C$676,601 | C$779,509 | C$932,538 | C$625,577 | C$990,600 | C$1.1M | C$1.2M |
| Total operating expenses | C$1.2M | C$1.4M | C$1.0M | C$1.2M | C$979,714 | C$1.0M | C$1.3M | C$1.6M | C$1.1M | C$729,952 | C$1.3M | C$1.4M |
| Operating income | −C$1.5M | −C$1.4M | −C$1.3M | −C$1.7M | −C$797,781 | −C$989,046 | −C$1.2M | −C$1.6M | −C$1.1M | −C$1.3M | −C$1.2M | −C$1.3M |
| Interest income | C$1,945 | C$1,815 | C$5,413 | C$6,684 | C$207 | C$173 | C$7,249 | — | — | — | — | — |
| Interest expense | C$191,262 | C$236,774 | C$278,562 | C$202,488 | C$109,744 | C$111,444 | C$108,004 | C$133,947 | C$108,402 | C$99,384 | C$96,103 | C$31,075 |
| Income before taxes | −C$1.7M | −C$1.6M | −C$1.6M | −C$1.3M | −C$907,318 | −C$196,366 | −C$1.3M | −C$1.7M | −C$1.2M | −C$1.4M | −C$1.2M | −C$1.3M |
| Net income | −C$1.7M | −C$1.6M | −C$1.6M | −C$1.3M | −C$907,318 | −C$196,366 | −C$1.3M | −C$1.7M | −C$1.6M | −C$1.4M | −C$1.2M | −C$1.3M |
| EBITDA | −C$1.3M | −C$1.1M | −C$1.0M | −C$876,153 | −C$570,973 | C$139,182 | −C$922,059 | −C$1.3M | −C$834,920 | −C$1.1M | −C$978,100 | −C$1.2M |
| Gross margin | −302.6% | 89.9% | — | — | 92.6% | 71.8% | 73.2% | −9.6% | 49.9% | −745.8% | 167.6% | 676.6% |
| Operating margin | −1,522.6% | −1,363.7% | — | — | −406.2% | −1,615.0% | −497.7% | −2,743.9% | −851.2% | −1,626.4% | −1,099.3% | −6,523.2% |
| Net margin | −1,715.0% | −1,599.9% | — | — | −462.0% | −320.6% | −541.0% | −2,978.2% | −1,311.6% | −1,741.5% | −1,182.4% | −6,644.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in Canadian dollars as reported in OPTH's financial statements (latest annual report filed September 30, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OPTH financial results
In fiscal year 2025 (ended September 30, 2025), Optimi Health Corp. reported revenue of C$0.4 million, up 9.5% from the year before. It had a net loss of C$3.7 million, a net profit margin of −870.8%. Figures are in Canadian dollars, the currency of its financial statements.
See the OPTH stock overview for the latest quote and news, or the OPTH chart for price history and technical indicators.
OPTH income statement FAQ
What is Optimi Health Corp.'s annual revenue?
Optimi Health Corp. reported total revenue of C$0.4 million for fiscal year 2025, which ended on September 30, 2025. That was up 9.5% from C$0.4 million the previous year.
Is Optimi Health Corp. profitable?
No. Optimi Health Corp. reported a net loss of C$3.7 million in fiscal 2025, a net profit margin of −870.8%; its operating margin was −1,062.3%.
What is Optimi Health Corp.'s gross margin?
Optimi Health Corp.'s gross margin was −486.4% in fiscal 2025: for every $100 of revenue, Optimi Health Corp. kept $-486 after the direct cost of its products and services.
How much does Optimi Health Corp. spend on research and development?
Optimi Health Corp. spent C$0.3 million on research and development in fiscal 2025, 81.6% of revenue.
When will Optimi Health Corp. report its next earnings?
Optimi Health Corp. is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
When does Optimi Health Corp.'s fiscal year end?
Optimi Health Corp.'s fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on September 30, 2025.